1-5 of 5
Michael Hsiao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma

Chia-Wen Liu, Kuo-Tai Hua, Kai-Chun Li, Hsiang-Fong Kao, Ruey-Long Hong, Jenq-Yuh Ko, Michael Hsiao, Min-Liang Kuo, Ching-Ting Tan
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (7): 1421–1434.
https://doi.org/10.1158/1535-7163.MCT-16-0567-T
Published: 04 July 2017
View article titled, Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma
Open the PDF for Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate–Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio

Ming-Hsien Chien, Wei-Min Chang, Wei-Jiunn Lee, Yu-Chan Chang, Tsung-Ching Lai, Derek V. Chan, Rahul Sharma, Yuan-Feng Lin, Michael Hsiao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (6): 1102–1113.
https://doi.org/10.1158/1535-7163.MCT-16-0314
Published: 01 June 2017
View article titled, A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio
Open the PDF for A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio in another window
Includes: Supplementary data
Journal Articles

Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression

Cheng-Chang Yeh, Yi-Ting Deng, De-Yuan Sha, Michael Hsiao, Mark Yen-Ping Kuo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (9): 2718–2725.
https://doi.org/10.1158/1535-7163.MCT-09-0211
Published: 17 September 2009
View article titled, Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression
Open the PDF for Suberoylanilide hydroxamic acid sensitizes human oral cancer cells to TRAIL-induced apoptosis through increase DR5 expression in another window
Journal Articles

Overexpressions of EGFP/LKB1 gene by lentivirus mediated gene delivery induced apoptosis and enhanced chemosensitivity in human lung cancers

Tzung-Ching Lai, Michael Hsiao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C284.
Published: 01 November 2007
View article titled, Overexpressions of EGFP/LKB1 gene by lentivirus mediated gene delivery induced apoptosis and enhanced chemosensitivity in human lung cancers
Journal Articles

Silatecan DB-67 is a novel DNA topoisomerase I–targeted radiation sensitizer

Allan Y. Chen, Shyh-Jen Shih, Liza N. Garriques, Mace L. Rothenberg, Michael Hsiao, Dennis P. Curran
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (2): 317–324.
https://doi.org/10.1158/1535-7163.317.4.2
Published: 15 February 2005
View article titled, Silatecan DB-67 is a novel DNA topoisomerase I–targeted radiation sensitizer
Open the PDF for Silatecan DB-67 is a novel DNA topoisomerase I–targeted radiation sensitizer in another window